Relay Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $10,007 |
Gross Profit | -1,368 | 8,612 | ||
EBITDA | -83,645 | -95,002 | -110,763 | -90,800 |
EBIT | -84,979 | -96,369 | -112,131 | -92,195 |
Net Income | -76,004 | -88,105 | -92,212 | -81,387 |
Net Change In Cash | 0 | 0 | 0 | 10,007 |
Free Cash Flow | -57,868 | -75,310 | -65,844 | -52,103 |
Cash | 124,287 | 152,357 | 134,125 | 152,866 |
Basic Shares | 167,337 | 140,229 | 132,821 | 130,843 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $10,007 | $25,546 | $1,381 | $3,029 |
Gross Profit | 10,007 | 20,277 | -2,749 | -896 |
EBITDA | -380,210 | -374,153 | -306,822 | -222,182 |
EBIT | -385,674 | -379,422 | -310,952 | -226,107 |
Net Income | -337,708 | -341,973 | -254,259 | -496,808 |
Net Change In Cash | 10,007 | 25,546 | 1,381 | 3,029 |
Cost of Revenue | -128,325 | -165,827 | ||
Free Cash Flow | -251,125 | -304,442 | -238,552 | -77,877 |
Cash | 124,287 | 143,736 | 998,917 | 958,073 |
Basic Shares | 142,867 | 122,576 | 112,233 | 95,136 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.45 |
2024-09-30 | -$0.63 |
2024-06-30 | -$0.69 |
2024-03-31 | -$0.62 |
